Fibrinolytic Agents
Mostrando 1-12 de 22 artigos, teses e dissertações.
-
1. In vitro characterization of jellyfish venom fibrin(ogen)olytic enzymes from Nemopilema nomurai
Abstract Background: Because jellyfish are capable of provoking envenomation in humans, they are considered hazardous organisms. Although the effects of their toxins are a matter of concern, information on the venom components, biological activity and pathological mechanisms are still scarce. Therefore, the aim of the present study was to investigate a seri
J. Venom. Anim. Toxins incl. Trop. Dis. Publicado em: 08/02/2018
-
2. Avaliação da atividade fibronolitica oral em pacientes sob anticoagulação oral / Evaluation of oral fibrinolytic activity of patients under oral anticoagulation
Fibrinolysis is a part of the haemostatic process that is responsible for reestablish the blood flow, by the dissolution of the fibrin clot formed after a vascular injury. This process can be altered by several factors, such as tissue trauma and presence of inflammatory or infectious process, which can increase the local fibrinolytic activity and, by that, c
Publicado em: 2009
-
3. Tratamento trombolítico intravenoso no acidente vascular cerebral isquêmico: experiência da clínica neurológica do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo / Intravenous thrombolytic therapy for acute ischemic stroke: clinical experience of Department of Neurology of the Hospital das Clínicas da Universidade de São Paulo
O uso intravenoso do ativador tecidual do plasminogênio está aprovado para o tratamento do acidente vascular cerebral isquêmico há alguns anos e estão publicadas diretrizes e recomendações para o seu uso. O atendimento hospitalar precisa ser organizado a fim de tornar esse tratamento exeqüível e seguro, alcançando os resultados esperados. O objetiv
Publicado em: 2007
-
4. Atividade de plasmina simile e sequencia parcial de enzima fibrino(geno)litica do veneno de Bothrops lanceolatus (Fer de lance)
The main symptoms following bothropic envenoming are necroses, hemorrhage and coagulopathies, originating a characteristic and complex phisiopathology. The work of Lôbo de Araújo et al. (1998) described a single polipeptide chain protein (PII-1A) purified from Bothrops lanceolatus venom, a snake inhabitant of the Martinica island. The immunodiffusion and i
Publicado em: 2005
-
5. Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results
OBJECTIVE: To assess the short- and long-term results of the use of streptokinase (SK) for the treatment of thromboses in cardiac valvular prostheses. METHODS: Seventeen patients with cardiac prosthetic thrombosis diagnosed by clinical, echocardiographic, and radioscopic findings underwent fibrinolytic treatment with a streptokinase bolus of 250,000 U follow
Arquivos Brasileiros de Cardiologia. Publicado em: 2003-10
-
6. Fibrinolytic agents in the treatment of tuberculous meningitis
-
7. Effects of fibrinolytic agents on experimental and clinical thrombosis
-
8. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors
As demonstrated by others, fibrinolytic activity was generated in diluted, acidified normal plasma exposed to kaolin, a process requiring Hageman factor (Factor XII). Generation was impaired by adsorbing plasma with glass or similar agents under conditions which did not deplete its content of Hageman factor or plasminogen. The defect could be repaired by add
-
9. Effect of biotin deficiency on some properties of Staphylococcus aureus isolates from humans and other animals.
Staphylococcus aureus isolates from humans and other animals were grown in biotin assay medium containing 12 mug of biotin per liter and compared to isolates from the same sources grown concurrently in medium containing adequate biotin. The two cultures were tested for production of coagulase, phosphatase, and fibrinolysin enzymes and for responses to variou
-
10. Fibrinolytic treatment of thrombus on prosthetic heart valves.
Fibrinolytic agents were administered for 13 episodes of thrombus formation on mitral or aortic valvar prostheses in 12 patients. The most common presenting features were pulmonary oedema (six cases) or arterial emboli (six cases). The diagnosis of thrombus formation was made by phonocardiography on the following criteria: (a) modifications of the prosthetic
-
11. Tranexamic acid-associated ligneous conjunctivitis with gingival and peritoneal lesions.
A considerable number of agents have been proposed as causing ligneous conjunctivitis. We report the first case to arise as a side effect of tranexamic acid (Cyclokapron), an anti-fibrinolytic drug used in the treatment of menorrhagia. In addition to the typical conjunctival changes our patient had lesions affecting the gingiva and the peritoneum the last ca
-
12. British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction.
Consultant physicians and cardiologists were surveyed early in 1987 and 1989 to document the management policies for the treatment of acute myocardial infarction in United Kingdom hospitals and to assess the influence of major clinical trials on these policies. The response rate to both these surveys was high (84% (1178 physicians) in 1987 and 76% (982 physi